Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA

CompletedOBSERVATIONAL

Enrollment

366

Participants

Timeline

Start Date

May 2, 2012

Primary Completion Date

May 1, 2013

Study Completion Date

December 31, 2016

Conditions

Nasopharyngeal CarcinomaEBV Related Carcinoma

All Listed Sponsors

lead

Taichung Veterans General Hospital

OTHER

NCT03314051 - Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA | Biotech Hunter | Biotech Hunter